Download
00784_2024_Article_5644.pdf 1,75MB
WeightNameValue
1000 Titel
  • Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma – results from a German tertiary medical center
1000 Autor/in
  1. Struckmeier, Ann-Kristin |
  2. Buchbender, Mayte |
  3. Lutz, Rainer |
  4. Kesting, Marco |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-20
1000 Erschienen in
1000 Quellenangabe
  • 28(5):262
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00784-024-05644-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032275/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Objectives</jats:title> <jats:p>This study aimed to explore survival and recurrence patterns in patients undergoing primarily surgical treatment for oral squamous cell carcinoma (OSCC) at a high-volume tertiary medical center in Germany.</jats:p> </jats:sec><jats:sec> <jats:title>Materials and methods</jats:title> <jats:p>The study included 421 patients with primary OSCC who underwent radical tumor resection, neck dissection, and reconstruction with a free flap. Prognostic relevance of clinicopathological characteristics was assessed using Cox proportional-hazards models. Kaplan-Meier method estimated local recurrence-free survival, progression-free survival (PFS), and overall survival (OS), while the log-rank test compared survival outcomes between groups.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Recurrence manifested in 16.63% of the patients (70 patients), encompassing local recurrence in 54 patients (77.14%) and distant metastasis in 24 patients (34.28%). Neck recurrence occurred in only 1 patient (0.24%) on the contralateral side. The majority of recurrences occurred within the initial twelve months following primary tumor surgery (64.29%). Overall, the 5-year OS stood at 58.29%, while the 5-year PFS reached 72.53%. Patients with early recurrence within ≤ 12 months showed the least favorable prognosis (log-rank, all <jats:italic>p</jats:italic> &lt; 0.001).</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Our findings show a significant decrease in recurrence rates and enhanced PFS at a high-volume tertiary medical center in Germany compared to previous studies. Local recurrence was the primary form observed, with most recurrences happening within the initial twelve months post-surgery. Opting for treatment at a high-volume center and devising therapy plans in interdisciplinary tumor boards may not only enhance OS but also contribute to improved PFS.</jats:p> </jats:sec><jats:sec> <jats:title>Clinical relevance</jats:title> <jats:p>These findings offer valuable insights for physicians regarding the post-treatment care of patients with OSCC. The results underscore the importance of frequent follow-up appointments, particularly during the initial year, and highlight the critical need for vigilance in monitoring for local recurrence.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Mouth Neoplasms/pathology [MeSH]
lokal Recurrence
lokal Humans [MeSH]
lokal Progression-Free Survival [MeSH]
lokal Retrospective Studies [MeSH]
lokal Neoplasm Recurrence, Local/pathology [MeSH]
lokal Squamous Cell Carcinoma of Head and Neck [MeSH]
lokal Oral squamous cell carcinoma
lokal Mouth Neoplasms/surgery [MeSH]
lokal Survival
lokal Free flap
lokal Research
lokal Head and Neck Neoplasms [MeSH]
lokal Prognosis [MeSH]
lokal Neck dissection
lokal Carcinoma, Squamous Cell/pathology [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-4015-1466|https://frl.publisso.de/adhoc/uri/QnVjaGJlbmRlciwgTWF5dGU=|https://frl.publisso.de/adhoc/uri/THV0eiwgUmFpbmVy|https://frl.publisso.de/adhoc/uri/S2VzdGluZywgTWFyY28=
1000 Hinweis
  • DeepGreen-ID: 230ac9a6ae03415f96dd8c4ffa99852f ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Erlangen |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Erlangen |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6519151.rdf
1000 Erstellt am 2025-07-05T16:00:20.117+0200
1000 Erstellt von 322
1000 beschreibt frl:6519151
1000 Zuletzt bearbeitet 2025-08-14T07:32:38.849+0200
1000 Objekt bearb. Thu Aug 14 07:32:38 CEST 2025
1000 Vgl. frl:6519151
1000 Oai Id
  1. oai:frl.publisso.de:frl:6519151 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source